Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

Trastuzumab 2Streptozocin 2tipifarnib 1romidepsin 1Sorafenib 1Pantoprazole 1Oxaliplatin 1Omeprazole 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Gefitinib 1Fluorouracil 1Floxuridine 1Doxorubicin 1Cisplatin 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Gastrinoma × Fluorouracil × Clear all
NCT00001165 2008-03-04

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
999 enrolled

Adenoma, Islet Cell, Neoplasm Metastasis, Zollinger-Ellison Syndrome, Gastrinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡